Article citationsMore>>

Stahl, M.M., Lindquist, M, Pettersson, M., Edwards, I.R., Sanderson, J.H., Taylor, N.F., Fletcher, A.P. and Schou, J.S. (1997) Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system. European Journal of Clinical Pharmacology, 53, 163-169. doi:10.1007/s002280050357

has been cited by the following article:

• TITLE: Withdrawal seizure associated with high dosage of aripiprazole and fluoxetine: a case report

  AUTHORS: Jian-An Su, Shih-Yong Chou, Ching-Shu Tsai, Tai-Hsin Hung

  KEYWORDS: Aripiprazole; High Dosage; Withdrawal Seizure

  JOURNAL NAME: Open Journal of Psychiatry, Vol.1 No.2, July 12, 2011

  ABSTRACT: Aripiprazole, a third-generation antipsychotic, has been considered to have a high safety profile and rare withdrawal symptoms. We reported the case of a schizophrenic patient with a significant obsession, who was treated with a high dosage of aripiprazole and fluoxetine. Generalized tonic-clonic seizure occurred two days after abruptly stopping these two medications. Gradually tapering aripiprazole is suggested in clinical practice, especially when using a high dosage.